AbbVie Inc. Price Today
AbbVie Inc.
ABBV
Healthcare
$300.66B
💰
Market Cap
62.4
💸
Price to Earnings
$2.7
🎉
EPS
+70
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
17 |
Strong Buy |
6 |
Hold |
12 |
Sell |
0 |
Strong Sell |
0 |
ABBV Price Forecast Target
169.8 👉 206.0 +21%
ABBV EPS Forecast
2.7 👉 12.2 +349%
Financials
Profit Margin
9 %
Revenue Growth
-5.4 %
Dividend
$ 6.2
Held Percent
0.1% - Insiders
71.9% - Institutions
28.0% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $27.2B
-
💰 Blackrock Inc. $24.3B
-
💰 State Street Corporation $13.3B
-
💰 JP Morgan Chase & Company $8.8B
-
💰 Capital International Investors $7.6B
Stock Ideas
Howard Marks Portfolio
Meet Howard Marks, the co-founder and lead of Oaktree Capital Management, a Los Angeles-based investment firm that manages roughly $78 billion in investment capital. Marks has an impressive background in distressed debt, high yield bonds, and conver…
Scott Ferguson Portfolio
With a strong background as a protégé of Bill Ackman, founder of Pershing Square Capital Management, Scott Ferguson has honed his skills and expertise in the art of activist investing. He possesses the ability to identify undervalued companies with …
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…📮FAQ
Some Frequently Asked Questions.
The AbbVie Inc. industry is Drug Manufacturers - General
The AbbVie Inc. sector is Healthcare
The AbbVie Inc. forecasted predicted Price to Earnings PE ratio is 13.9
The AbbVie Inc. Price to Earnings PE ratio is 62.4
The Market Capitalization of AbbVie Inc. is $300.66B
There are total of 1762604782 float shares with 71.9% held by Institutions and 0.1% held by insiders
The MAbbVie Inc. forecasted Earnings per Share EPS is $12.2
The AbbVie Inc. Earnings per Share EPS is 2.7
The AbbVie Inc. company has $0 gross profits with 9 profit margins
The AbbVie Inc. Earnings Growth is -0.669% with -0.668% quarterly earnings growth
The AbbVie Inc. Revenue is $54317998080 with -0.054 revenue growth
The price target for AbbVie Inc. stock is $206.0 for the high target and $161.0 for the low target
The consensus analyst recommendations for AbbVie Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for AbbVie Inc. is Buy, with the following breakdown:
- Buy: 17
- Strong Buy: 6
- Hold: 12
- Sell: 0
- Strong Sell: 0
The Beta of AbbVie Inc. is 0.6
The dividend of AbbVie Inc. is $6.2
The dividend yield of AbbVie Inc. is 0.0344%
The biggest institutional and mutual fund holders of AbbVie Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- JP Morgan Chase & Company
The AbbVie Inc. ESG Score is 70, with the following breakdown:
- E: 2.38
- S: 17.19
- G: 10.36